QualityStocksNewsBreaks Archives

ThursdayJun 26, 2025 11:32 am

QualityStocksNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Sees 245% Surge in Juve Stabia Valuation Following Promotion Playoff Run

Brera Holdings (NASDAQ: BREA), an Ireland-based company executing a multi-club ownership strategy in global football, announced that its portfolio club S.S. Juve Stabia recorded the highest market value increase in Italy’s Serie B for the 2024–25 season. According to Virgilio Sport, the club’s valuation rose 245% to US$32 million, driven by a strong on-field performance and promotion playoff run. Brera finalized its 52% controlling stake in Juve Stabia on June 20, 2025, following FIGC approval. Executive Chairman Daniel McClory credited the growth to Brera’s operational and player development strategy. To view the full press release, visit https://ibn.fm/ZJHvS About Brera Holdings…

ThursdayJun 26, 2025 10:15 am

QualityStocksNewsBreaks – Channelchek by Noble Highlights Steelcase (NYSE: SCS) Beats Q1 FY26 Expectations with Strong Margins and EPS Upside

Channelchek, a Noble Financial Group, Inc. product and service, reports that Steelcase (NYSE: SCS) delivered first-quarter fiscal 2026 results ahead of expectations, with revenue rising 7% year over year to $779 million—above both the $760 million forecast and $762 million consensus. Gross margin improved to 33.9%, surpassing guidance, while adjusted EPS reached $0.20, topping Noble’s $0.14 estimate and the $0.13 Street consensus. Strength in the Americas, especially among corporate, government, and healthcare customers, drove the gains. Orders dipped slightly overall, with 1% growth internationally offset by a 1% decline in the Americas. Looking ahead, Steelcase expects flat to 4% revenue…

ThursdayJun 26, 2025 9:30 am

QualityStocksNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Highlights PC111 Breakthrough After Scientist Wins Top Italian Dermatology Award

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharma company focused on inflammation and immunology, announced that Dr. Roberta Lotti of Pincell Srl has won the "Oscar of Italian Dermatology" from SIDeMaST for her research on PC111, a first-in-class anti-Fas Ligand monoclonal antibody. The study, published under the title "Blocking soluble Fas Ligand ameliorates pemphigus", confirms PC111’s ability to block blister formation by preventing keratinocyte apoptosis in pemphigus vulgaris. Scinai holds an option to acquire Pincell and is advancing PC111 as a lead asset, emphasizing its potential as a non-immunosuppressive, disease-modifying treatment for severe autoimmune skin conditions. To view the full press release,…

WednesdayJun 25, 2025 3:09 pm

QualityStocksNewsBreaks – As Gold Continues to Shine, Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Offers Compelling Investment Opportunity

In an era marked by economic volatility and geopolitical tensions, gold is once again proving its value as a top safe-haven asset. Amid reignited interest in gold mining ventures, companies such as Lahontan (TSX.V: LG) (OTCQB: LGCXF) are emerging as compelling opportunities for investors seeking exposure to the precious metals sector. “Lahontan has positioned itself as a noteworthy player in the gold exploration and development landscape,” reads a recent article. “The company boasts a portfolio of four gold and silver projects located in Nevada’s prolific Walker Lane, a region renowned for its rich mineral endowment and mining-friendly jurisdiction. Lahontan’s flagship asset, the…

WednesdayJun 25, 2025 2:28 pm

QualityStocksNewsBreaks – Nightfood Holdings Inc. (NGTF) Poised to Disrupt Hospitality with AI and Automation

Nightfood Holdings’ (OTCQB: NGTF) new leadership team is poised to leverage combined expertise to facilitate the company’s growth and innovation. The company recently appointed Jimmy Chan as chief executive officer and Ried Floco as president and director. The executives bring strong track records in a variety of spaces, including the hospitality sector, where automation and artificial intelligence are reshaping service. The move is “part of Nightfood’s broader initiative to integrate robotics into the hospitality industry, aiming to enhance efficiency and customer experience,” reads an article discussing the strategic appointments. “As Nightfood Holdings embarks on its next growth phase, the addition of…

WednesdayJun 25, 2025 12:30 pm

QualityStocksNewsBreaks – FAVO Capital Inc. (FAVO) Eyes Opportunity at Crossroads of Fintech Innovation, Lending Demand

As traditional banks retreat from Main Street, alternative lenders are stepping up to fill the gap, reshaping the $1.7 trillion small business lending market. With policymakers calling for renewed focus on small business financing and digital platforms redefining borrower access, private credit firms like FAVO Capital (OTC: FAVO) are emerging as essential players in the financial ecosystem. Leveraging scalable technology, a seasoned leadership team, and a growing syndication network, FAVO is positioning for growth at the intersection of market demand and digital transformation. “At the heart of FAVO’s competitive advantage is its technology-focused lending model. The company continues to build and refine…

WednesdayJun 25, 2025 11:50 am

QualityStocksNewsBreaks – Titan Partners Group LLC Leads $200 Million Private Placement for Quantum Computing (NASDAQ: QUBT)

Titan Partners, a division of American Capital Partners, is acting as sole placement agent in a $200 million private placement for Quantum Computing Inc. (NASDAQ: QUBT), an integrated photonics and quantum optics technology company. The offering involves the sale of 14,035,089 shares of common stock to institutional investors at $14.25 per share. Quantum Computing intends to use the proceeds to accelerate commercialization, pursue strategic acquisitions, and support working capital and general corporate needs. To view the full press release, visit https://ibn.fm/uMVdV About Titan Partners Group LLC Titan Partners Group LLC (“Titan Partners”), a division of American Capital Partners, LLC (“ACP”) is…

WednesdayJun 25, 2025 9:15 am

QualityStocksNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Expands Fingerprint Drug Testing Across Scandinavia with Spjotgard Partnership

Intelligent Bio Solutions (NASDAQ: INBS), a medical technology firm specializing in non-invasive drug screening, reported continued success in its partnership with Spjotgard, a Scandinavian distributor. The collaboration is accelerating adoption of INBS’ fingerprint-based Drug Screening System across Sweden, Norway, and Denmark, with Finland showing rising interest. The technology offers a less invasive, hygienic alternative to urine and saliva tests, delivering results in under 10 minutes and gaining traction in sectors like logistics, education, and criminal justice. Spjotgard’s growing regional presence and strategic alliances position INBS to scale further in Northern Europe. To view the full article, visit https://ibn.fm/PJPCa About Intelligent…

TuesdayJun 24, 2025 10:45 am

QualityStocksNewsBreaks – BioAdaptives, Inc. (OTC Pink: BDPT) to Launch Pawpa(TM) Regen Nationwide as Stem Cell-Based Canine Supplement Gains Momentum

BioAdaptives (OTC Pink: BDPT), a leader in nutraceutical and wellness innovation, will launch its proprietary canine supplement Pawpa(TM) Regen nationwide by the end of July 2025. Designed to support natural stem cell activation in aging dogs, the supplement has shown promising results in early trials, including improved energy, mobility, coat quality, and temperament. CEO James Keener emphasized the product’s unique regenerative approach using safe, naturally sourced ingredients. With strong early feedback and growing demand for holistic pet care solutions, BioAdaptives is expanding production ahead of the broader e-commerce rollout. To view the full press release, visit https://ibn.fm/Y6PRK About BioAdaptives, Inc.…

TuesdayJun 24, 2025 9:10 am

QualityStocksNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Taps IBN to Lead Corporate Communications Amid Drug Advancements and Subsidiary Launch

NRx Pharmaceuticals (NASDAQ: NRXP) a clinical-stage biopharmaceutical company developing innovative treatments for suicidal depression and PTSD, has engaged IBN to manage its corporate communications strategy. NRx is advancing two FDA-designated therapies—NRX-100 and NRX-101—with an NDA underway for NRX-100 and additional regulatory filings in progress. The company also launched HOPE Therapeutics, a subsidiary focused on building a national psychiatric care network, with plans for a public spin-out. IBN will leverage its extensive media portfolio to expand investor awareness and outreach. To view the full press release, visit https://ibn.fm/L8kUd About NRx Pharmaceuticals, Inc. NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics…

Site Search

Company Search

Category: QualityStocksNewsBreaks